AGICC’s Medical Director, Dr. Lawrence Leichman to Present Poster at ASCO 2012 Meeting

Larry Leichman, MD (AGICC Medical Director) and Steve Cohen, MD (PI at Fox Chase Cancer Center) were notified on April 9th that the OSI abstract submitted to ASCO 2012 was accepted as a poster and is scheduled for presentation Monday, June 4th, 8AM-12 noon. The abstract (#99936) is a review of the AGICC managed study titled: A Phase 1B Study of Erlotinib in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Previously Untreated Advanced Pancreatic Cancer, An Academic Oncology GI Cancer Consortium Study. Dr. Lawrence Leichman is first author; Dr. Steven Cohen is last author.

Recommended Posts